Aquaporin-4 antibody neuromyelitis optica spectrum disorder: A paraneoplastic disease?

Abstract

Get full access to this article

View all access options for this article.

References

Kunchok

Flanagan

Snyder

, et al. Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD. Mult Scler 2021; 27(4): 630–635.

Graus

Vogrig

Muñiz-Castrillo

, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 2021; 8(4): e1014.

Leite

Coutinho

Lana-Peixoto

, et al. Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients. Neurology 2012; 78: 1601–1607.

Tardo

LWC

Rajaram

, et al. Pediatric paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian teratoma. Mult Scler 2021. Epub ahead of print. DOI: 10.1177/13524585211037582.

Levy

Fujihara

Palace

New therapies for neuromyelitis optica spectrum disorder. Lancet Neurol 2021; 20: 60–67.

Ikeguchi

Shimizu

Shimomura

, et al. Paraneoplastic AQP4-IgG–seropositive neuromyelitis optica spectrum disorder associated with teratoma: A case report and literature review. Neurol Neuroimmunol Neuroinflamm 2021; 8(5): e1045.